// App-Quantinova.ai

DOP06 : Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in ulcerative colitis and may predict response to vedolizumab therapy

Researchers

Presenter

  • S Hermangild Kottoor

Principal Investigators

  • Z Kassam

  • P Pavlidis

  • E Alberts

  • H Ibraheim

  • L Constable

  • J Digby-Bell

  • D Warren

  • S Odukwe

  • M Samaan

  • P Irving

  • J Sanderson

  • N Powell

Medical Centers

  • King’s College London, School of Immunology and Microbial Sciences, London, United Kingdom

  • Guys and St Thomas Hospitals NHS Foundation Trust, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • C-C Motif Chemokine Receptor 7

  • Cluster of Differentiation 25

  • Cluster of Differentiation 4

  • C-X-C motif chemokine receptor 3

  • Regulatory T cells

  • T helper 2

  • Type 1 T helper

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved